Loading
Latest filing published 26 May 2026 for Beta Bionics, Inc., €8,562. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam Lezack is a declared insider of Beta Bionics, Inc., with filings sourced from SEC (Form 4). Between 15 March 2025 and 22 May 2026, the trades on record add up to 7 filings.
On the market, this insider has only sold: 4 sales, €73k in total. Other entries cover 3 share grants. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 26 May 2026 with an open-market sale (€8,562) in Beta Bionics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations